Epidermal necrolysis in the context of immuno-oncologic medication as well as kinase inhibitors and biologics.

Ziemer, Mirjana; Fries, Viviane; Paulmann, Maren; Mockenhaupt, Maja

Ziemer, Mirjana; Fries, Viviane; Paulmann, Maren; Mockenhaupt, Maja.

Afiliação

Ziemer M; Department of Dermatology, Venereology and Allergology, University Hospital Leipzig, Germany.
Fries V; German Center for the Documentation of Severe Skin Reactions (dZh), Department of Dermatologie, Medical Center and Medical Faculty - University of Freiburg, Germany.
Paulmann M; German Center for the Documentation of Severe Skin Reactions (dZh), Department of Dermatologie, Medical Center and Medical Faculty - University of Freiburg, Germany.
Mockenhaupt M; German Center for the Documentation of Severe Skin Reactions (dZh), Department of Dermatologie, Medical Center and Medical Faculty - University of Freiburg, Germany.

J Dtsch Dermatol Ges ; 20(6): 777-786, 2022 06.

Article em En | MEDLINE | ID: mdl-35711043

Assuntos

Produtos Biológicos; Toxidermias; Síndrome de Stevens-Johnson; Produtos Biológicos/efeitos adversos; Toxidermias/diagnóstico; Toxidermias/etiologia; Humanos; Nivolumabe; Rituximab; Síndrome de Stevens-Johnson/diagnóstico; Síndrome de Stevens-Johnson/etiologia; Síndrome de Stevens-Johnson/patologia; Vemurafenib

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Produtos Biológicos / Síndrome de Stevens-Johnson / Toxidermias Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies Limite: Humans Idioma: En Revista: J Dtsch Dermatol Ges Assunto da revista: DERMATOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google